Loading...

Propidium Iodide Solution

Pricing & Availability
Regulatory Status
RUO
Other Names
PI
Ave. Rating
Submit a Review
Product Citations
publications
See Propidium Iodide spectral data
Cat # Size Price Quantity Check Availability Save
421301 2 mL 44€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Propidium iodide (PI) is a fluorescent dye that binds to DNA. When excited by 488nm laser light, it can be detected with in the PE/Texas Red® channel with a bandpass filter 610/10. It is commonly used in evaluation of cell viability or DNA content in cell cycle analysis by flow cytometry.

Product Details
Technical data sheet

Product Details

Formulation
Phosphate-buffered saline, pH 7.2, containing 0.09% sodium azide.
Concentration
0.5 mg/ml
Storage & Handling
The solution should be stored undiluted between 2°C and 8°C, and protect from light. Caution: This solution contains hazardous material; handle with care.
Application

FC - Quality tested
Recommended Usage

The suggested use of this solution for viability staining is 10 µl per million cells in 0.5 ml/test, and incubate for 15 minutes at 4 °C before analysis. For Cell Cycle analysis, please see our Propidium Iodide Cell Cycle Staining Protocol. Caution: This solution is toxigenic and mutagenic; handle with care.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Propidium Iodide Solution can be used in evaluation of apoptosis, cell viability and cell cycle analysis by flow cytometry.

Application References

(PubMed link indicates BioLegend citation)
  1. Vermes I, et al.1995. J. Immunol. Methods 184:39.
  2. Darzynkiewicz Z, et al. 1992. Cytometry 13(8):795.
  3. Douglas RS, et al. 1995. J. Immunol. Methods 188:219.
  4. Sakimoto I, et al. 2006. Cancer Research 66:2287.PubMed
  5. Liu H, et al. 2012. Int J Biochem Cell Biol. 45:408. PubMed
  6. Juel HB, et al. 2013. PLoS One. 8:64619. PubMed
  7. Ren Q, et al. 2013. PLoS One. 8:74732. PubMed
  8. Zhao W, et al. 2013. Clin Immunol. 149:119. PubMed
  9. Beggs KM, et al. 2014. Toxicol Sci. 137:91. PubMed
  10. Ewald SE, et al. 2014. Infect Immun. 82:460. PubMed
  11. Tsou WI, et al. 2014. J Biol Chem. 289:25750. PubMed
  12. Kong S, et al. 2014. J Immunol. 193:5515. PubMed
Product Citations
  1. Li W, et al. 2019. Aging (Albany NY). 0.99375. PubMed
  2. Evans SJ, et al. 2022. Toxicol In Vitro. 83:105415. PubMed
  3. Hagege A, et al. 2022. Cell Rep Med. 3:100659. PubMed
  4. Tintelnot J, et al. 2023. Nature. 615:168. PubMed
  5. Ohuchi K, et al. 2023. Biomed Rep. 18:28. PubMed
  6. Quintela M, et al. 2023. Clin Epigenetics. 15:63. PubMed
  7. Buckley MT, et al. 2023. Nat Aging. 3:121. PubMed
  8. Quintela M, et al. 2023. Br J Cancer. . PubMed
  9. Sohrabi N, et al. 2023. Iran J Public Health. 52:633. PubMed
  10. Papsdorf K, et al. 2023. Nat Cell Biol. 25:672. PubMed
  11. Schwartz PB, et al. 2023. PLoS Genet. 19:e1010770. PubMed
  12. Wyrobnik I, et al. 2023. Oncoimmunology. 12:2219164. PubMed
  13. Glynn RA, et al. 2022. J Immunol. 208:371. PubMed
  14. Marques de Menezes EG, et al. 2022. MBio. 13:e0300521. PubMed
  15. Das Gupta D, et al. 2022. Cell Death Differ. 29:2163. PubMed
  16. Qin L, et al. 2022. Sci Adv. 8:eabn3774. PubMed
  17. Cheng Y, et al. 2022. Cell Mol Gastroenterol Hepatol. 14:964. PubMed
  18. Choi UY, et al. 2022. Cell Rep. 40:111234. PubMed
  19. Park J, et al. 2022. Animals (Basel). 12: . PubMed
  20. Papakonstantinou A, et al. 2022. Int J Mol Sci. 24: . PubMed
  21. Blal K, et al. 2023. Cancers (Basel). 15: . PubMed
  22. Xiong E, et al. 2023. Front Immunol. 13:1083119. PubMed
  23. Tanaka T, et al. 2023. Nat Immunol. 24:439. PubMed
  24. Bhardwaj M, et al. 2023. J Clin Invest. :. PubMed
  25. Hochrein SM, et al. 2022. Cell Metab. 34:516. PubMed
  26. Wenes M, et al. 2022. Cell Metab. 34:731. PubMed
  27. Liu H, et al. 2012. Int J Biochem Cell Biol. 45:408. PubMed
  28. Ewald S, et al. 2014. Infect Immun . 82:460. PubMed
  29. Guo H, et al. 2016. Sci Rep. 6:37559. PubMed
  30. Smith A, et al. 2017. Sci Rep. 7:41872. PubMed
  31. Chan J, et al. 2017. Oncogene. 10.1038/onc.2017.319. PubMed
  32. Uroda T, et al. 2019. Mol Cell. 75:982. PubMed
  33. Lindqvist B, et al. 2022. PLoS Pathog. 18:e1010555. PubMed
  34. Neumann CKA, et al. 2020. Mol Metab. 34:136. PubMed
  35. Hamel Y, et al. 2021. Cell Rep Med. 2:100370. PubMed
  36. Castellanos CA, et al. 2021. Sci Immunol. 6:eabh0707. PubMed
  37. Leeth C, et al. 2021. Animals (Basel). 11:. PubMed
  38. Chen M, et al. 2021. Cancers (Basel). 13:. PubMed
  39. McNeal AS, et al. 2021. Elife. 10:. PubMed
  40. He Y, et al. 2020. Nat Commun. 11:1996. PubMed
  41. Fukushima T, et al. 2019. Cell Rep. 29:4144. PubMed
  42. Yoshioka H, et al. 2021. Front Cell Dev Biol. 9:621045. PubMed
  43. Yang Y, et al. 2021. Metabolism. 123:154863. PubMed
  44. Sun X, et al. 2022. JCI Insight. 7: . PubMed
  45. Coray M, et al. 2022. Int J Mol Sci. 23:. PubMed
  46. Ren Q, et al. 2013. PLoS One. 8:74732. PubMed
  47. Zeng H, et al. 2018. Cancer Cell. 34:56:00. PubMed
  48. Lei W, et al. 2020. Sci Rep. 10:7004. PubMed
  49. Wang Y, et al. 2019. Cell. 179:1144. PubMed
  50. Zhang M, et al. 2017. Oncol Lett. 3.069444444. PubMed
  51. Zhang W, et al. 2021. J Clin Invest. 131:. PubMed
  52. Ambrosi TH, et al. 2021. Elife. 10: . PubMed
  53. Schrier S, et al. 2016. Sci Rep. 6:34942. PubMed
  54. O'Neill K, et al. 2016. Genes Dev. 30: 973-988. PubMed
  55. Sapanidou V, et al. 2015. Theriogenology. . PubMed
  56. Kong S, et al. 2014. J Immunol. 193:5515. PubMed
  57. Chen C, et al. 2019. Cell Rep. 29:4200. PubMed
  58. Liu L, et al. 2019. Cell Prolif. :e12718. PubMed
  59. Zou PA, et al. 2021. Oncol Lett. 22:648. PubMed
  60. Masuda T, et al. 2022. iScience. 25:104781. PubMed
  61. Feng L, et al. 2016. J Cell Sci. 129: 2202 - 2212. PubMed
  62. Lange N, et al. 2016. PLoS One. 11: 0160843. PubMed
  63. Jordan PM, et al. 2020. Cell Rep. 33:108247. PubMed
  64. Liu Y, et al. 2017. Acta Biomater. 10.1016/j.actbio.2017.08.021. PubMed
  65. Reighard SD, et al. 2020. Cell Rep Med. :1. PubMed
  66. Zhang S, et al. 2020. Front Immunol. 1.757638889. PubMed
  67. Xu B, et al. 2016. Leukemia. 10.1038/leu.2016.297. PubMed
  68. Yang M, et al. 2021. Med Sci Monit. 27:e930083. PubMed
  69. Domenis R, et al. 2017. PLoS One. 10.1371/journal.pone.0169932. PubMed
  70. Walter F, et al. 2020. PLoS One. 15:e0239369. PubMed
  71. Liu H, et al. 2020. Cell Death Dis. 0.767361111. PubMed
  72. Li L, et al. 2018. Oncol Lett. 4.184722222. PubMed
  73. Jung E, et al. 2017. J Neurosci. 37:6837. PubMed
  74. Basso-Ricci L, et al. 2017. Cytometry A. 10.1002/cyto.a.23148. PubMed
  75. Matsuda K, et al. 2021. Cell Rep Methods. 1:100122. PubMed
  76. Pang K, et al. 2022. Cell Death Dis. 13:169. PubMed
  77. Tang X, et al. 2021. Transl Cancer Res. 10:2120. PubMed
  78. Zhang X, et al. 2020. Eur J Med Chem. 112186:192. PubMed
  79. Mensen A, et al. 2015. Biol Blood Marrow Transplant. Available online 10 August 2015. PubMed
  80. Zhao W, et al. 2013. Clin Immunol. 149:119. PubMed
  81. Litzenburger UM, et al. 2017. Genome Biol. 18:15. PubMed
  82. Shanahan MT, et al. 2021. Am J Physiol Gastrointest Liver Physiol. 321:G668. PubMed
  83. Wang J, et al. 2022. J Clin Invest. :. PubMed
  84. Trudu M, et al. 2022. Front Oncol. 12:968208. PubMed
  85. Li Y, et al. 2016. Int J Lower Extrem Wounds. 10.1177/1534734616649485. PubMed
  86. Hu D, et al. 2020. Proc Natl Acad Sci U S A. 117:30639. PubMed
  87. Li Q, et al. 2020. Acta Biochim Biophys Sin (Shanghai). 52:1131. PubMed
  88. Moribe F, et al. 2021. PLoS One. 16:e0237554. PubMed
  89. Perl AL, et al. 2019. J Biol Chem. 294:17043. PubMed
  90. Diaz Osterman CJ, et al. 2019. Elife. 8:e47327. PubMed
  91. Hosokawa T, et al. 2017. J Immunol. 10.4049/jimmunol.1700157. PubMed
  92. El-Hafeez A, et al. 2017. Cytotechnology. 10.1007/s10616-017-0124-1. PubMed
  93. Xue G, et al. 2021. Nat Biomed Eng. 5:1306. PubMed
  94. Lasrado N, et al. 2022. iScience. 25:103865. PubMed
  95. L Chang, Y Li, D Kaplan 2016. Sci Rep. 6:36862. PubMed
  96. Tsou W, et al. 2014. J Biol Chem. 289:25750. PubMed
  97. Oubaha M, et al. 2016. Sci Transl Med. 8: 362ra144. PubMed
  98. Polk A, et al. 2016. Clin Cancer Res. 22(24):6118-6128. PubMed
  99. El-Hafeez A, et al. 2017. Cytotechnology. 10.1007/s10616-017-0116-1. PubMed
  100. Xie M, et al. 2017. BMC Cancer . 10.1186/s12885-017-3291-8. PubMed
  101. Pal P, et al. 2021. J Med Chem. 64:14230. PubMed
  102. Hedemann N, et al. 2021. Cancers (Basel). 13:. PubMed
  103. Xie B, et al. 2021. J Immunol. 206:1515. PubMed
  104. Harro CM, et al. 2020. J Clin Invest. . PubMed
  105. Imura Y, et al. 2020. JCI Insight. :5. PubMed
  106. Suzuki S, et al. 2021. STAR Protocols. 2:100683. PubMed
  107. Vickman R, et al. 2016. Mol Cancer Res. 14: 776 - 786. PubMed
  108. Huang K, et al. 2018. Biol Open. 7:bio029470. PubMed
  109. Wang H, et al. 2019. Nat Commun. 4.388194444. PubMed
  110. Matsubara T, et al. 2022. J Exp Med. 219:. PubMed
  111. M H, et al. 2016. Cell Transplant. 25: 811-27. PubMed
  112. Woo MS, et al. 2021. J Exp Med. :218. PubMed
  113. Liu X, et al. 2019. Mol Cancer Ther. 18:706. PubMed
  114. Yang X, et al. 2017. J Control Release. 10.1016/j.jconrel.2017.07.014. PubMed
  115. Viereckl MJ, et al. 2022. Biomolecules. 12:. PubMed
  116. Deng Y, et al. 2021. Nat Commun. 12:7041. PubMed
  117. Hughes K, et al. 2017. Open Bio. 10.1098/rsob.160155. PubMed
  118. Resch U, et al. 2016. MBio. 7: e00207-16. PubMed
  119. Bao W, et al. 2016. Sci Rep. 6:22579. PubMed
  120. Bjørnstad R, et al. 2019. Mol Cancer Ther. 1.14375. PubMed
  121. Ghura H, et al. 2021. Neoplasia. 23:837. PubMed
  122. Beggs K, et al. 2014. Toxicol Sci. 137:91. PubMed
  123. Wang C, et al. 2017. Drug Deliv. 10.1080/10717544.2017.1293195. PubMed
  124. Nilsri N, et al. 2021. Sci Rep. 5255:11. PubMed
  125. He Y, et al. 2020. J Hematol Oncol. 0.607638889. PubMed
  126. Widodo N, et al. 2022. F1000Res. 11:169. PubMed
  127. Tu Z, et al. 2022. Cell Rep. 40:111072. PubMed
  128. Bensberg M, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  129. Siddhartha V, et al. 2017. Artif Cells Nanomed Biotechnol . 10.1080/21691401.2017.1313267. PubMed
  130. Viseshakul N, et al. 2017. Parasitol Res. 10.1007/s00436-017-5589-5. PubMed
  131. Chmielewski M and Abken H 2017. Cell Rep.. 10.1016/j.celrep.2017.11.063. PubMed
  132. Sakimoto I, et al. 2006. Cancer Res. 66:2287. PubMed
  133. Goel S, et al. 2021. Nat Commun. 12:5325. PubMed
  134. Szeto C, et al. 2022. Nat Commun. 13:4951. PubMed
  135. Namas R, et al. 2016. Lupus Sci Med. 3: e000148. PubMed
  136. Chen Y, et al. 2016. J Biol Chem. 291: 13216 - 13228. PubMed
  137. Deng BB, et al. 2020. Cell Biol Int. 44:1890. PubMed
  138. Popa S, et al. 2020. Wellcome Open Res. 0.249305556. PubMed
  139. Vulin M, et al. 2022. Oncogene. :. PubMed
  140. Liu Q, et al. 2016. Cell Death Dis. 1.93125. PubMed
  141. Mahmoudi M, et al. 2016. Sci Rep. 6:26960. PubMed
  142. Juel H, et al. 2013. PLoS One. 8:64619. PubMed

Antigen Details

Biology Area
Cell Biology, Cell Cycle/DNA Replication, Neuroscience
Gene ID
NA

Related FAQs

Why is washing not recommended after the addition 7-AAD or PI addition when assessing viability?

These dyes bind in equilibrium with DNA. Therefore, external dye concentration must be maintained during analysis and the dye should not be washed out.

Go To Top Version: 2    Revision Date: 10.08.2015

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account